Medigene AG verstärkt Management-Team durch Ernennung von drei Senior Vice Presidents
Die Medigene AG (MDG1, Frankfurt, Prime Standard), ein Immuntherapie-Unternehmen mit klinischen Entwicklungsprojekten f…
Die Medigene AG (MDG1, Frankfurt, Prime Standard), ein Immuntherapie-Unternehmen mit klinischen Entwicklungsprojekten f…
Medigene AG (MDG1, Frankfurt, Prime Standard), a clinical stage immunotherapy company focussing on the development of T…
Sistemic Ltd. ("Sistemic"), a leading provider of microRNA-based problem-solving services and kit-based products, has fo…
Cytori Therapeutics (NASDAQ: CYTX) has obtained approval to sell the Celution® 800 System in Russia for various medical…
Cytori Therapeutics (NASDAQ: CYTX) will present and provide a corporate update from the Jefferies 2012 Global Healthcare…
During the first quarter of 2012, Cytori Therapeutics (NASDAQ: CYTX) advanced its cardiac cell therapy product pipeline,…
Cytori Therapeutics (NASDAQ: CYTX) announced today the publication of RESTORE-2 trial results in the peer-reviewed Europ…
Cytori (NASDAQ: CYTX) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Puregraft®…
In 2011, Cytori Therapeutics (NASDAQ: CYTX) achieved important objectives towards validating Celution® technology in mul…
Cytori Therapeutics (NASDAQ: CYTX) has received an Investigational Device Exemption (IDE) approval from the U.S. FDA to…